COVID-19
More than half of US states will relax lockdowns by the end of the week
April 30, 2020Business Services COVID-19, Lockdown, coronavirus, quaratine
Nearly half of US states will have their ‘stay-at-home’ orders expire this week, paving the way for much of the …
Two studies reveal “positive” data for Gilead’s remdesivir in hospitalised COVID-19 patients
April 30, 2020Research and Development COVID-19, Gilead, coronavirus, remdesivir
The first findings of two new studies have been revealed detailing the efficacy of Gilead’s antiviral therapy remdesivir in the …
Men most likely to exhibit the worst COVID-19 symptoms, according to a new study
April 30, 2020Business Services COVID-19, coronavirus
Research into coronavirus cases in Shenzhen, China found that men were 2.5 times as likely to exhibit severe symptoms. The …
Australia calls for investigation into China’s coronavirus response
April 29, 2020Research and Development Australia, COVID-19, China, coronavirus
Scott Morrison, the Australian Prime Minister, has called for an investigation into the origins of the COVID-19 coronavirus, as Australia …
Pharmafile.com’s weekly COVID-19 news round-up
April 29, 2020Research and Development BARDA, COVID-19, coronavirus, hydroxychloroquine
Hydroxychloroquine continues to feature in coronavirus news. Rick Bright, the Director of BARDA, alleges he was pushed out of his …
Nearly half of Americans believe COVID-19 was created in a lab, according to a new survey
April 28, 2020Manufacturing and Production COVID-19, coronavirus, survey
Almost half of Americans believe that the coronavirus was created in a lab, according to an April survey of 6,300 …
The May 2020 issue of Pharmafocus is available to read free online now!
April 28, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, pharma
The latest monthly edition of Pharmafocus, the May 2020 issue, is available to read for free online now!
South Korean researchers start testing pancreatitis drug in COVID-19 patients
April 28, 2020Manufacturing and Production COVID-19, Pancreas, Pancreatitis, coronavirus
The South Korean Ministry of Food and Drug Safety have approved a local trial to evaluate nafamostat’s effectiveness in COVID-19 …
12 British children hospitalised with rare condition linked to COVID-19
April 28, 2020Manufacturing and Production COVID-19, NHS, NHS UK, coronavirus
12 children have fallen ill across the UK with a new and potentially fatal combination of symptoms linked to COVID-19. …
Italy to relax COVID-19 lockdown in early May
April 27, 2020Sales and Marketing COVID-19, COVID-19 coronavirus, Italy, coronavirus
Italy has outlined its plans to ease the lockdown restrictions that were implemented across the country 7 weeks ago to …
Researchers studying heartburn drug as potential coronavirus treatment
April 27, 2020Sales and Marketing COVID-19, Pepcid, coronavirus, pandemic
Researchers in America have been studying famotidine, the active ingredient in Pepcid, as a potential treatment for COVID-19. Pepcid is …
‘Excess deaths’ in England among the highest in Europe
April 27, 2020Sales and Marketing COVID-19, coronavirus, deaths, pandemic
English excess deaths from the coronavirus are comparable to the worst hit countries in Europe, according to a Sky News …
FDA urges close monitoring of COVID-19 patients treated with hydroxychloroquine
April 27, 2020Sales and Marketing COVID-19, FDA, chloroquine, coronavirus, hydroxychloroquine
The FDA has released a safety communication reiterating the need for doctors to closely monitor COVID-19 patients who are treated …
Leading COVID-19 hope remdesivir fails to provide clinical benefit in first randomised trial
April 24, 2020Medical Communications, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage …
Top Ten most popular articles on Pharmafile.com this week
April 24, 2020Medical Communications COVID-19, coronavirus, top 10
Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
